Molecules and Cells

Cited by CrossRef (49)

  1. Xi Chen, Zhijie Xu, Shuangshuang Zeng, Xiang Wang, Wanli Liu, Long Qian, Jie Wei, Xue Yang, Qiuying Shen, Zhicheng Gong, Yuanliang Yan. SIRT5 downregulation is associated with poor prognosis in glioblastoma. CBM 2019;24:449
    https://doi.org/10.3233/CBM-182197
  2. Jonathan L. Warren, Nancie J. MacIver. Regulation of Adaptive Immune Cells by Sirtuins. Front. Endocrinol. 2019;10
    https://doi.org/10.3389/fendo.2019.00466
  3. Thomas L. Pulliam, Pavithr Goli, Dominik Awad, Chenchu Lin, Sandi R. Wilkenfeld, Daniel E. Frigo. Regulation and role of CAMKK2 in prostate cancer. Nat Rev Urol 2022;19:367
    https://doi.org/10.1038/s41585-022-00588-z
  4. Anandika Dhaliwal, Sandra Pelka, David S. Gray, Prabhas V. Moghe. Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules. Sci Rep 2018;8
    https://doi.org/10.1038/s41598-018-34511-7
  5. Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg-Wiklund. One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies. Epigenomes 2021;5:22
    https://doi.org/10.3390/epigenomes5040022
  6. Mahmut Gozelle, Selen Gozde Kaya, Ahmet Bugra Aksel, Erva Ozkan, Filiz Bakar-Ates, Yesim Ozkan, Gokcen Eren. Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity. Bioorganic Chemistry 2022;123:105746
    https://doi.org/10.1016/j.bioorg.2022.105746
  7. Robert A.H. van de Ven, Daniel Santos, Marcia C. Haigis. Mitochondrial Sirtuins and Molecular Mechanisms of Aging. Trends in Molecular Medicine 2017;23:320
    https://doi.org/10.1016/j.molmed.2017.02.005
  8. Minh Nguyen, Milán Somogyvári, Csaba Sőti. Hsp90 Stabilizes SIRT1 Orthologs in Mammalian Cells and C. elegans. IJMS 2018;19:3661
    https://doi.org/10.3390/ijms19113661
  9. de Céu Teixeira, Sanchez-Lopez, Espina, Garcia, Durazzo, Lucarini, Novellino, Souto, Santini, Souto. Sirtuins and SIRT6 in Carcinogenesis and in Diet. IJMS 2019;20:4945
    https://doi.org/10.3390/ijms20194945
  10. Chandra Sekhar Challa, Naresh Kumar Katari, Varadacharyulu Nallanchakravarthula, Devanna Nayakanti, Ravikumar Kapavarapu, Manojit Pal. Wang-OSO3H catalyzed green synthesis of 2-arylamino-3-cyanopyridine derivatives under ultrasound: Their assessment as potential inhibitors of SIRT1. Journal of Molecular Structure 2022;1253:132309
    https://doi.org/10.1016/j.molstruc.2021.132309
  11. Nina Schmid, Kim-Gwendolyn Dietrich, Ignasi Forne, Alexander Burges, Magdalena Szymanska, Rina Meidan, Doris Mayr, Artur Mayerhofer. Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors. IJMS 2021;22:2047
    https://doi.org/10.3390/ijms22042047
  12. Xiaohan Yue, Yulu Shi, Qing Luo. Advances of SIRT4 in cancer metabolism and therapy. Pediatric Discovery 2023;1
    https://doi.org/10.1002/pdi3.17
  13. Sandeep Sundriyal, Sébastien Moniot, Zimam Mahmud, Shang Yao, Paolo Di Fruscia, Christopher R. Reynolds, David T. Dexter, Michael J. E. Sternberg, Eric W.-F. Lam, Clemens Steegborn, Matthew J. Fuchter. Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket. J. Med. Chem. 2017;60:1928
    https://doi.org/10.1021/acs.jmedchem.6b01690
  14. Seung Min Jeong, Sunsook Hwang, Rho Hyun Seong. SIRT4 regulates cancer cell survival and growth after stress. Biochemical and Biophysical Research Communications 2016;470:251
    https://doi.org/10.1016/j.bbrc.2016.01.078
  15. Vincenzo Carafa, Lucia Altucci, Angela Nebbioso. Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.00038
  16. Daniela Tomaselli, Clemens Steegborn, Antonello Mai, Dante Rotili. Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer. Front. Oncol. 2020;10
    https://doi.org/10.3389/fonc.2020.00474
  17. Giuseppina Di Stefano, Marcella Manerba, Lorenza Di Ianni, Luigi Fiume. Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment. Future Medicinal Chemistry 2016;8:713
    https://doi.org/10.4155/fmc.16.10
  18. Jing‐Ru Weng, Eman M. E. Dokla, Li‐Yuan Bai, Ching‐Shih Chen, Shih‐Jiuan Chiu, Tzong‐Ming Shieh. A 5′ AMP‐Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral Squamous Cell Carcinoma. Basic Clin Pharma Tox 2018;123:21
    https://doi.org/10.1111/bcpt.12976
  19. Lijun Yao, Yinhua Wang, Sheba Mohankumar. Bioinformatic Analysis of the Effect of the Sirtuin Family on Differentiated Thyroid Carcinoma. BioMed Research International 2022;2022:1
    https://doi.org/10.1155/2022/5794118
  20. Luís Gaspar, Ross P. Coron, Paul KongThoo Lin, David M. Costa, Begoña Perez-Cabezas, Joana Tavares, Meritxell Roura-Ferrer, Isbaal Ramos, Céline Ronin, Louise L. Major, Fabrice Ciesielski, Iain K. Pemberton, Jane MacDougall, Paola Ciapetti, Terry K. Smith, Anabela Cordeiro-da-Silva, Igor C. Almeida. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease. PLoS Negl Trop Dis 2018;12:e0006180
    https://doi.org/10.1371/journal.pntd.0006180
  21. Han Dai, David A. Sinclair, James L. Ellis, Clemens Steegborn. Sirtuin activators and inhibitors: Promises, achievements, and challenges. Pharmacology & Therapeutics 2018;188:140
    https://doi.org/10.1016/j.pharmthera.2018.03.004
  22. Sarika Kondabanthini, Naresh Kumar Katari, Malempati Srimannarayana, Rambabu Gundla, Ravikumar Kapavarapu, Manojit Pal. Wang resin catalyzed sonochemical synthesis of dihydropyrano[2,3-c]pyrazole derivatives and their interactions with SIRT1. Journal of Molecular Structure 2022;1266:133527
    https://doi.org/10.1016/j.molstruc.2022.133527
  23. Hongyan Li, Zhiyou Cai. SIRT3 regulates mitochondrial biogenesis in aging-related diseases. J Biomed Res 2023;37:77
    https://doi.org/10.7555/JBR.36.20220078
  24. Rohan Gupta, Rashmi K. Ambasta, Pravir Kumar. Multifaced role of protein deacetylase sirtuins in neurodegenerative disease. Neuroscience & Biobehavioral Reviews 2022;132:976
    https://doi.org/10.1016/j.neubiorev.2021.10.047
  25. Yuhan Chen, Di Zhou, Yuan Feng, Bingxin Li, Yong Cui, Gang Chen, Ning Li. Association of sirtuins (SIRT1-7) with lung and intestinal diseases. Mol Cell Biochem 2022;477:2539
    https://doi.org/10.1007/s11010-022-04462-9
  26. Jaroslav Zelenka, Martina Koncošová, Tomáš Ruml. Targeting of stress response pathways in the prevention and treatment of cancer. Biotechnology Advances 2018;36:583
    https://doi.org/10.1016/j.biotechadv.2018.01.007
  27. Sankarathi Balaiya, Khaled K. Abu-Amero, Altaf A. Kondkar, Kakarla V. Chalam. Sirtuins Expression and Their Role in Retinal Diseases. Oxidative Medicine and Cellular Longevity 2017;2017:1
    https://doi.org/10.1155/2017/3187594
  28. Ankita Adhikary, Agradeep Mukherjee, Riddhi Banerjee, Shirisha Nagotu. DRP1: At the Crossroads of Dysregulated Mitochondrial Dynamics and Altered Cell Signaling in Cancer Cells. ACS Omega 2023
    https://doi.org/10.1021/acsomega.3c06547
  29. Raviteja Chemboli, Unati Sai Kodali, Amit Kumar Taneja, Vinu Bandaru, Bhuvan Tej Mandava, Vijayavardhini Suryadevara, Bhagya Tej Mandava, K.R.S. Prasad, Ravikumar Kapavarapu, Mandava Venkata Basaveswara Rao, Manojit Pal. Sonochemical replacement of C-3 hydrogen of indole by a pyridine ring: Docking, synthesis and in vitro evaluation of 3-(6-aryl pyridin-2-yl)indoles against SIRT1. Journal of Molecular Structure 2024;1298:137025
    https://doi.org/10.1016/j.molstruc.2023.137025
  30. Vera Miranda-Gonçalves, Catarina Guimarães-Teixeira, Rui Henrique, Carmen Jerónimo. Epigenetics and Metabolomics. 2024.
    https://doi.org/10.1016/B978-0-323-85652-2.00019-1
  31. Nikil Purushotham, Mrityunjay Singh, Bugga Paramesha, Vasantha Kumar, Sharad Wakode, Sanjay K. Banerjee, Boja Poojary, Shailendra Asthana. Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors. RSC Adv. 2022;12:3809
    https://doi.org/10.1039/D1RA06149F
  32. Mrityunjay Singh, Mitul Srivastava, Sharad R. Wakode, Shailendra Asthana. Elucidation of Structural Determinants Delineates the Residues Playing Key Roles in Differential Dynamics and Selective Inhibition of Sirt1–3. J. Chem. Inf. Model. 2021;61:1105
    https://doi.org/10.1021/acs.jcim.0c01193
  33. Vera Miranda-Gonçalves, Ana Lameirinhas, Rui Henrique, Carmen Jerónimo. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets. Front. Genet. 2018;9
    https://doi.org/10.3389/fgene.2018.00427
  34. Shih-Bo Huang, D. Thapa, A.R. Munoz, S.S. Hussain, X. Yang, R.G. Bedolla, P. Osmulski, M.E. Gaczynska, Z. Lai, Yu-Chiao Chiu, Li-Ju Wang, Y. Chen, P. Rivas, C. Shudde, R.L. Reddick, H. Miyamoto, R. Ghosh, A.P. Kumar. Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling. Cancer Letters 2021;505:24
    https://doi.org/10.1016/j.canlet.2021.02.008
  35. Sarika Kondabanthini, Parameswari Akshinthala, Naresh Kumar Katari, Malempati Srimannarayana, Rambabu Gundla, Ravikumar Kapavarapu, Manojit Pal. A rapid synthesis of 5-substituted 7-amino-6-cyano-1,5-dihydro-1H-pyrano[2,3-d]pyrimidine-2,4(3H)-diones and their in silico / evaluation against SIRT1. Journal of Molecular Structure 2023;1276:134753
    https://doi.org/10.1016/j.molstruc.2022.134753
  36. Zhen Mei, Xian Zhang, Jiarong Yi, Junjie Huang, Jian He, Yongguang Tao. Sirtuins in metabolism, DNA repair and cancer. J Exp Clin Cancer Res 2016;35
    https://doi.org/10.1186/s13046-016-0461-5
  37. Murat Kadir Sukuroglu, Mahmut Gozelle, Yesim Ozkan, Gokcen Eren. The potential of 4-aryl-6-morpholino-3(2H)-pyridazinone-2-arylpiperazinylacetamide as a new scaffold for SIRT2 inhibition: in silico approach guided by pharmacophore mapping and molecular docking. Med Chem Res 2021;30:1915
    https://doi.org/10.1007/s00044-021-02782-x
  38. Seungyeon Yang, Sunsook Hwang, Jiho Jang, Minjoong Kim, Jihye Gwak, Seung Min Jeong. PGC1α is required for the induction of contact inhibition by suppressing ROS. Biochemical and Biophysical Research Communications 2018;501:739
    https://doi.org/10.1016/j.bbrc.2018.05.059
  39. Ahmed H. Tantawy, Xiang-Gao Meng, Adel A. Marzouk, Ali Fouad, Ahmed H. Abdelazeem, Bahaa G. M. Youssif, Hong Jiang, Man-Qun Wang. Structure-based design, synthesis, and biological evaluation of novel piperine–resveratrol hybrids as antiproliferative agents targeting SIRT-2. RSC Adv. 2021;11:25738
    https://doi.org/10.1039/D1RA04061H
  40. Hemalatha Kotakommula, Vaishnavi Chintala, Satya Sree Nannapaneni, Naresh Kumar Katari, Ravikumar Kapavarapu, Manojit Pal. Wang resin catalyzed sonochemical synthesis of 2-amino-3,5-dicarbonitrile-6-thio-pyridines as potential inhibitors of SIRT1. Journal of Molecular Structure 2024;1295:136756
    https://doi.org/10.1016/j.molstruc.2023.136756
  41. Luis Filipe Costa-Machado, Pablo J. Fernandez-Marcos. The sirtuin family in cancer. Cell Cycle 2019;18:2164
    https://doi.org/10.1080/15384101.2019.1634953
  42. Swagata Adhikari, Deblina Guha, Chitra Mohan, Shravanti Mukherjee, Jessica K. Tyler, Chandrima Das. Metabolism and Epigenetic Regulation: Implications in Cancer. 2019.
    https://doi.org/10.1007/978-3-031-07634-3_1
  43. Barbara Zdzisińska, Aleksandra Żurek, Martyna Kandefer-Szerszeń. Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use. Arch. Immunol. Ther. Exp. 2017;65:21
    https://doi.org/10.1007/s00005-016-0406-x
  44. Mohamed O. Radwan, Halil I. Ciftci, Taha F.S. Ali, Ryoko Koga, Hiroshi Tateishi, Akiko Nakata, Akihiro Ito, Minoru Yoshida, Mikako Fujita, Masami Otsuka. Structure activity study of S-trityl-cysteamine dimethylaminopyridine derivatives as SIRT2 inhibitors: Improvement of SIRT2 binding and inhibition. Bioorganic & Medicinal Chemistry Letters 2020;30:127458
    https://doi.org/10.1016/j.bmcl.2020.127458
  45. Bojana Uzelac, Ana Krivokuca, Mirjana Brankovic-Magic, Zvonko Magic, Snezana Susnjar, Zorka Milovanovic, Gordana Supic. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer. Pathol. Oncol. Res. 2020;26:2723
    https://doi.org/10.1007/s12253-020-00873-5
  46. Nadia A. Khalil, Eman M. Ahmed, Ashraf F. Zaher, Mona S. El-Zoghbi, Eman A. Sobh. Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors. European Journal of Medicinal Chemistry 2020;187:111926
    https://doi.org/10.1016/j.ejmech.2019.111926
  47. Marjan Ajami, Hamidreza Pazoki-Toroudi, Hamed Amani, Seyed Fazel Nabavi, Nady Braidy, Rosa Anna Vacca, Atanas Georgiev Atanasov, Andrei Mocan, Seyed Mohammad Nabavi. Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols. Neuroscience & Biobehavioral Reviews 2017;73:39
    https://doi.org/10.1016/j.neubiorev.2016.11.022
  48. Christian Marx, Lisa Marx-Blümel, Nora Lindig, René Thierbach, Doerte Hoelzer, Sabine Becker, Susan Wittig, Roland Lehmann, Hortense Slevogt, Thorsten Heinzel, Zhao-Qi Wang, James F. Beck, Jürgen Sonnemann. The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing’s sarcoma cell line. Invest New Drugs 2018;36:396
    https://doi.org/10.1007/s10637-017-0541-1
  49. Talita H.B. Gomig, Tayana S. Jucoski, Erika P. Zambalde, Alexandre L.K. Azevedo, Daniela F. Gradia, Enilze M.S.F. Ribeiro. Sirtuin Biology in Cancer and Metabolic Disease. 2018.
    https://doi.org/10.1016/B978-0-12-822467-0.00013-9